Pharmacology and pharmacokinetics of methotrexate in rheumatic disease - Practical issues in treatment and design

被引:33
作者
Hillson, JL
Furst, DE
机构
[1] Arthritis Clinical Research Unit, Virginia Mason Medical Center, Seattle, WA 98101
关键词
D O I
10.1016/S0889-857X(05)70359-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Methotrexate (MTX) is among the most effective drugs for treatment of rheumatoid arthritis and has been proven valuable in the treatment of multiple other disorders of immune regulation. MTX has been administered at a wide range of doses and dose intervals, in conjunction with multiple other drugs, and in patients with a broad range of concomitant disorders. To design a safe and effective MTX treatment plan for an individual patient, the provider must have knowledge of the pharmacology and drug interactions of this effective but potentially dangerous medication. The first section of the article reviews MTX structure, pharmacology, pharmacokinetics, and mechanisms of action in rheumatic disease. The second section examines factors that can be used to Increase MTX efficacy and decrease toxicity.
引用
收藏
页码:757 / &
页数:24
相关论文
共 135 条
[1]   PROLONGATION AND ENHANCEMENT OF SERUM METHOTREXATE CONCENTRATIONS BY PROBENECID [J].
AHERNE, GW ;
PIALL, E ;
MARKS, V ;
MOULD, G ;
WHITE, WF .
BRITISH MEDICAL JOURNAL, 1978, 1 (6120) :1097-1099
[2]   METHOTREXATE-INDUCED RENAL-FAILURE AND INEFFECTIVENESS OF PERITONEAL-DIALYSIS [J].
AHMAD, S ;
SHEN, F ;
BLEYER, WA .
ARCHIVES OF INTERNAL MEDICINE, 1978, 138 (07) :1146-1147
[3]   INHIBITION OF PHOSPHORIBOSYLAMINOIMIDAZOLECARBOXAMIDE TRANSFORMYLASE BY METHOTREXATE AND DIHYDROFOLIC ACID POLYGLUTAMATES [J].
ALLEGRA, CJ ;
DRAKE, JC ;
JOLIVET, J ;
CHABNER, BA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (15) :4881-4885
[4]  
ALLEGRA CJ, 1985, J BIOL CHEM, V260, P9720
[5]  
ANAYA JM, 1994, J RHEUMATOL, V21, P203
[6]   DIFFERENCES IN METHOTREXATE AND 7-HYDROXYMETHOTREXATE INHIBITION OF FOLATE-DEPENDENT ENZYMES OF PURINE NUCLEOTIDE BIOSYNTHESIS [J].
BAGGOTT, JE ;
MORGAN, SL ;
VAUGHN, WH .
BIOCHEMICAL JOURNAL, 1994, 300 :627-629
[7]   INHIBITION OF 5-AMINOIMIDAZOLE-4-CARBOXAMIDE RIBOTIDE TRANSFORMYLASE, ADENOSINE-DEAMINASE AND 5'-ADENYLATE DEAMINASE BY POLYGLUTAMATES OF METHOTREXATE AND OXIDIZED FOLATES AND BY 5-AMINOIMIDAZOLE-4-CARBOXAMIDE RIBOSIDE AND RIBOTIDE [J].
BAGGOTT, JE ;
VAUGHN, WH ;
HUDSON, BB .
BIOCHEMICAL JOURNAL, 1986, 236 (01) :193-200
[8]  
BALINSKA M, 1981, CANCER RES, V41, P2751
[9]  
BALLIS FM, 1983, CANCER RES, V42, P2342
[10]   POLYGAMMAGLUTAMYL METABOLITES OF METHOTREXATE [J].
BAUGH, CM ;
KRUMDIECK, CL ;
NAIR, MG .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1973, 52 (01) :27-34